SCHEMBL12812066

SCHEMBL12812066

O=C(Nc1ccc(-c2ccc3ncc(N4CCCCC4)nc3c2)cc1)NC1CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.46
▸ PIK3CA P42336 2/20 0.44
▸ EPHX1 P07099 3/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ GAA P10253 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ EPHX2 P34913 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ GBA1 P04062 1/20 0.42
▸ TP53 P04637 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ HSPA1A P0DMV8 1/20 0.41
▸ THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1442411 0.90 GAA (0.52) ATMPIK3CAGAAEPHX2GBA1
SCHEMBL10178945 0.88 KDR (0.43) ATMPIK3CAEPHX1KDM4EMEN1
SCHEMBL12811797 0.85 CKS1B (0.50) PIK3CAMEN1KMT2ANPC1RAB9A
SCHEMBL1442447 0.84 CYP1A2 (0.50) PIK3CAKDM4EMEN1ALDH1A1KMT2A
SCHEMBL1443207 0.82 CXCR4 (0.49) PIK3CAKMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL1442311 0.80 BMPR1B (0.47) PIK3CAMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL12812416 0.80 PIK3CA (0.47) PIK3CAMEN1KMT2ANPC1RAB9A
SCHEMBL1443006 0.80 CKS1B (0.45) ATMPIK3CA
SCHEMBL12811787 0.78 HTR2C (0.51) KDM4EALDH1A1KMT2ANPC1RAB9A
SCHEMBL1442689 0.78 SMN1; SMN2 (0.56) KDM4EMEN1ALDH1A1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 — — WO disclosed
Send feedback